Published on November 27, 2009 at 1:18 AM
Research and Markets (http://www.researchandmarkets.com/research/2070d2/osteoporosis_thera) has announced the addition of the "Osteoporosis Therapeutics - A Global Market Perspective" report to their offering.
Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America, Europe, and Japan. Afflicting millions of people across the world, the potentially life-threatening disease - osteoporosis poses a major clinical challenge to the medical world. Major therapeutic classes currently available include bisphosphonates, Estrogen Replacement Therapy (ERT) drugs, calcitonins and Selective Estrogen Receptor Modulators (SERMs). Parathyroid Hormone (PTH)-based drugs comprise the most recent genre of therapeutics with new bone-forming potential. As osteoporosis is asymptomic, several cases of osteoporosis are detected only after experiencing a fracture.
These and other market data and trends are presented in "Osteoporosis Therapeutics: A Global Market Perspective" by BizAcumen, Inc. This report is designed to be the most comprehensive in geographic coverage and vertical market analyses.
http://www.researchandmarkets.com/research/2070d2/osteoporosis_thera